Mi-1001

N/A

Report date: 2026/01/22 16:42:39
NME

Base Information

Drug NameMi-1001
Drug Alias NameMi-1001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 agonists
TargetsToll like receptor 7
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMorphimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesMorphimmune Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A